-
Economic Burden Associated with Negative Symptoms Identified Through Natural Language Processing Among Patients with Schizophrenia in the United States Schizophr. Bull. (IF 5.3) Pub Date : 2025-06-03
Jerome Vaccaro, Mona Nili, Pin Xiang, James K Nelson, Cory Pack, Randall Thompson, Joe Vasey, Joseph ParksBackground and Hypothesis The objective of this study was to identify documented negative symptoms of schizophrenia using natural language processing (NLP) and to characterize treatment patterns, healthcare resource utilization (HCRU), and costs among this patient population. Study Design This US retrospective cohort study used electronic health records (EHR) linked to administrative claims data from
-
Screening for Cognitive Decline in Psychotic Disorders in Midlife: Examining Scoring the Clinical Dementia Rating Using Longitudinal Data Schizophr. Bull. (IF 5.3) Pub Date : 2025-06-02
Sean A P Clouston, Katherine Jonas, Constantine G Lyketsos, Wen Xuan Lian, Yuan Yang, Philip D Harvey, Evelyn J Bromet, Roman KotovBackground and Hypothesis Little is understood about whether the high reported prevalence of dementia in people with psychosis reflects impairment present at psychosis onset. We hypothesized that relying on longitudinal data would help to distinguish stable deficits associated with psychotic disorders from subsequent decline. Study Design We prospectively assessed the Clinical Dementia Rating (CDR)
-
Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP Biotypes Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-31
Liisi Promet, Shashwath A Meda, Ney Alliey-Rodriguez, Brett A Clementz, Elliott S Gershon, Scot K Hill, Elena I Ivleva, Sarah K Keedy, Matcheri S Keshavan, Jennifer E McDowell, David A Parker, Carol A Tamminga, Godfrey D PearlsonBackground and Hypothesis The brain age gap (BAG) quantifies the difference between predicted brain age and chronological age. Prior research implicates higher BAG in psychotic disorders, suggesting accelerated brain aging. We hypothesized distinct brain aging profiles among biological subtypes of psychosis and intermediate BAG in their relatives. Study Design Brain age gap values were quantified in
-
Prebiotics Rescue Gut Microbiome Dysregulation and Enhance Cognitive and Gastrointestinal Function in a Mouse Model of Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-28
Carolina Gubert, Geraldine Kong, Sheida Shadani, Sasha Connell, Bethany A Masson, Nicholas van de Garde, Vinod K Narayana, Thibault Renoir, Anthony J HannanBackground and Hypothesis Schizophrenia is a devastating psychiatric disorder characterized by positive (eg, hallucinations) and negative (eg, reduced motivation) symptoms, and cognitive deficits. Chronic gastrointestinal tract issues exist as comorbid symptoms of schizophrenia. Recent findings indicate the involvement of the microorganisms that inhabit the gut, the microbiota (and the broader microbiome
-
Severe Outcomes and Length of Stay Among People With Schizophrenia Hospitalized for COVID-19: A Population-Based Retrospective Cohort Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-28
Jessica Gronsbell, John Wang, Hilary Thurston, Jianhui Gao, Yaqi Shi, Anthony D Train, Debra Butt, Andrea Gershon, Braden O’Neill, Karen TuBackground Schizophrenia is associated with substantial physical and psychiatric comorbidities that increase the risk of severe outcomes in COVID-19 infection. However, few studies have examined the differences in care and outcomes among people with schizophrenia throughout the pandemic. We hypothesized that rates of in-hospital mortality, admission to the intensive care unit (ICU), and length of stay
-
Antipsychotic Discontinuation and Re-initiation in Pregnant Women With Schizophrenia: A Retrospective Cohort Study From South Korea Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-28
Jiyeon Kim, Julia Kaminska, Ye-Jee Kim, Sung Woo Joo, Bo Ram YangBackground and Hypothesis Pregnant women with schizophrenia are more likely to discontinue treatment, which could trigger a relapse of symptoms. However, data on patterns and risk factors related to antipsychotic discontinuation and re-initiation in Asian pregnant women are insufficient. Study Design We conducted a retrospective cohort study using a nationwide Korean database. The pregnancy group included
-
Delineating the Transmission of Subthreshold Psychosis Symptoms Across Generations: The Philadelphia Family Neurodevelopmental Cohort Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-27
Lauren K White, Monica E Calkins, Megan M Himes, Tyler M Moore, Ruben C Gur, Ran Barzilay, Raquel E GurBackground and Hypothesis Intergenerational factors are implicated in development of schizophrenia spectrum disorders. Studying psychosis spectrum (PS) symptoms dimensionally in a longitudinal, prospective intergenerational cohort can provide crucial insight into risk pathways. Thus, we established the Philadelphia Family Neurodevelopmental Cohort (PFNC), an intergenerational study that follows Philadelphia
-
Advancing Understanding of Treatment Response in Schizophrenia With Psychosis Using a Novel Dynamic Reward Task Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-27
Ju-Chun Pei, Chia-Yuan Chang, Ya-Wen Liu, Ching Chen, Ching-Yi Liu, Ming H Hsieh, Chih-Min Liu, Wen-Sung LaiBackground and Hypothesis Schizophrenia presents significant treatment challenges, particularly due to medication resistance observed in some patients receiving antipsychotics. Emerging research suggests a potential link between impaired reinforcement learning, the severity of psychotic symptoms, and dopamine system abnormalities. Exploring reinforcement learning in therapeutic settings could provide
-
Schizophrenia-Related Synaptic Dysfunction and Abnormal Sensorimotor Gating in Akap11-Deficient Mice Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-23
Ya-Qi Zhang, Xin Cai, Qing Zhang, Mei-Yu Yin, Yingqi Guo, Cong Li, Guolan Ma, Lu Wang, Hong Chang, Xiao Xiao, Shi-Wu Li, Ming LiBackground and Hypothesis Large-scale whole exome sequencing (WES) analyses have implicated rare protein-truncating variants (PTVs) in the AKAP11 gene contributing to schizophrenia risk. Previous studies reported alterations of EEG characteristics and synaptic proteome in Akap11 mutant mice. We hypothesize that synaptic dysfunction contributes to AKAP11 deficiency in the pathogenesis of schizophrenia
-
Blunted Niacin Skin Flushing Response in Schizophrenia: A Meta-analysis Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-22
Jinfeng Wang, Qian Wang, Dandan Wang, Yan Gao, Shuhui Li, Tianqi Wang, Hao Liu, Huiling Wang, Xiaowen Hu, Chunling WanBackground and Hypothesis The multifactorial pathogenesis of schizophrenia (SZ) hinders the diagnosis and treatment of this disorder. Niacin skin flushing response (NSFR) has been identified as an endophenotype for SZ, but the proportion of blunted NSFR (BNR) varied between studies. This study aims to clarify the relationship between NSFR and SZ through a meta-analysis. Study Design PubMed, Embase
-
How Can We Better Assist Caregivers With Understanding and Addressing the Cognitive Health Needs of People With Psychotic Disorders? Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-22
Shayden Bryce, Amanda Sorenson, Debbie Warner, Alex Stainton, Alice Medalia, Caroline Cellard, Isabel Zbukvic, Jacquie Uren, Jessy Smith, Lauren Libeson, Wilma Peters, Kelly AllottCognitive impairment is a prominent feature of psychosis-spectrum disorders that impedes functional recovery. Globally, clinical guidelines recommend that evidence-based treatments, including cognitive remediation and cognitive compensation, are offered to people with psychosis with cognitive impairment. Clinical guidelines also recommend that, where possible, family is involved in the mental health
-
From Idealist to Realist—Designing and Implementing Shared Decision-Making Interventions in the Choice of Antipsychotic Prescription in People Living with Psychosis (SHAPE): A Realist Review Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-21
Ita Fitzgerald, Laura J Sahm, Ian Maidment, Emma Wallace, Yaara Zisman-Ilani, Mikkel Højlund, Sarah O’Dwyer, Ciara Ní Dhubhlaing, Erin K Crowley, Jo HoweBackground Shared decision-making (SDM) implementation remains limited in psychosis management, particularly within antipsychotic prescribing. When and why prescribers engage in SDM within these contexts is largely unknown. Part 1 of this two-part realist review aimed to understand the impact of structural and contextual factors on prescriber engagement in SDM within antipsychotic prescribing. Study
-
From Idealist to Realist—Designing and Implementing Shared Decision-Making Interventions in the Choice of Antipsychotic Prescription in People Living With Psychosis (SHAPE): A Realist Review (Part 2—Designing SDM Interventions: Optimizing Design and Local Implementation) Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-21
Ita Fitzgerald, Jo Howe, Ian Maidment, Emma Wallace, Yaara Zisman-Ilani, Mikkel Højlund, Sarah O’Dwyer, Ciara Ní Dhubhlaing, Erin K Crowley, Laura J SahmBackground Shared decision-making (SDM) implementation remains limited in psychosis management, particularly within antipsychotic prescribing. When and why prescribers engage in SDM within these contexts is largely unknown. Part 2 of this 2-part realist review aimed to understand what SDM intervention strategies and local implementation contexts are responsible for successful prescriber engagement
-
Predictors and Outcomes Associated with 25-Year Cognitive Decline in Psychotic Disorders Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-19
Yuan Yang, Sean A P Clouston, Abraham Reichenberg, Jennifer L Callahan, Camilo Javier Ruggero, Gabrielle A Carlson, Evelyn J Bromet, Roman Kotov, Katherine JonasBackground and Hypothesis Cognitive impairment, a key feature of psychosis, is linked to poor functional outcomes. This study aimed to identify predictors and outcomes associated with cognitive decline in psychotic disorders. Study Design Data were taken from the Suffolk County Mental Health Project, a first-admission longitudinal cohort study of individuals with psychotic disorders. Participants were
-
Longitudinal Development of Neurocognitive Functioning and Gray Matter Volume in Youths With Recurrent Psychosis Spectrum Symptoms Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-18
Ting Yat Wong, Tyler M Moore, Noah Hillman, Monica E Calkins, Sarah Shahriar, Tyler Dietterich, Kosha Ruparel, David R Roalf, Daniel H Wolf, Theodore D Satterthwaite, Arielle Ered, Raquel E Gur, Ruben C GurBackground and Hypothesis Neurodevelopmental risk-factor models of psychosis highlight the importance of early developmental deviations in the emergence of psychosis. However, few longitudinal studies map neurodevelopment and neurocognitive trajectories across age in preclinical psychosis. We investigated longitudinal trajectories in neurocognition and brain volume in a community cohort of adolescents
-
Restoring Course as a Core Diagnostic Element of Psychotic Disorders Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-18
Bruce M Cohen, Dost ÖngürBackground Foundational models of the psychoses included course as a core element differentiating patients. Current models, ICD-11 and DSM-5, only require symptom criteria to be met to make a diagnosis. We explore the proposition that making course designation essential, again, would improve the categorization of patients with psychotic disorders. Study Design We briefly discuss the history by which
-
Psychosocial Management of First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-12
Noosha Niv, Fuad Issa, Richard Goldberg, Pia R Khandekar, Kate McGraw, James T Reston, Shannon Ford, Ira Katz, Sandra G ResnickBackground Despite the large number of people treated for first-episode psychosis and schizophrenia within the Departments of Defense (DOD) and Veterans Affairs (VA), neither the DOD nor VA had established formal recommendations for the treatment of these conditions. This gap led Congress to require the development of clinical practice guidelines (CPG) for the treatment of schizophrenia. This paper
-
Transdiagnostic Neurocognitive Endophenotypes for Schizophrenia, Bipolar I Disorder and a Broad Psychosis/Bipolar I Disorder Phenotype: A Mega-Analysis of Twin and Sibling Data Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-09
Eugenia Kravariti, Anna-Maria Fragkaki, Anna Georgiades, Alastair G Cardno, Fergus Kane, Sridevi Kalidindi, Katja K Schulze, Colm McDonald, Marco M Picchioni, Mei-Hua Hall, Cameron J Watson, Birte Y Glenthøj, Bjørn H Ebdrup, Birgitte Fagerlund, Cecilie K Lemvigh, Neeltje E M Van Haren, Rene Kahn, Robin M Murray, Fruhling Rijsdijk, Timothea ToulopoulouBackground Psychiatric research is increasingly embracing a paradigm shift from categorical diagnoses to neurobiologically meaningful dimensions that cross current diagnostic boundaries. This transposition calls for redefining endophenotypes to accommodate transdiagnostic vulnerabilities. We sought to identify shared and disorder-specific neurocognitive endophenotypes for schizophrenia, bipolar I disorder
-
The Association Between Psychotropic Medications and Cognitive Functioning in a Real-World Cohort of 869 Individuals with Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-08
Faith Dickerson, Andrea Origoni, Emily Katsafanas, Kelly Rowe, Sabahat Khan, Allana Therese Calahatian, Fahad Mukhtar, Robert YolkenBackground Cognitive deficits are a central feature of schizophrenia for which there are not any established pharmacological treatments. Antipsychotics are the mainstay of schizophrenia therapy but the effects of these and other psychotropic medications on the cognitive functioning of people schizophrenia have not been extensively studied in routine real-world settings. Study Design A total of 869
-
Enhancing Coordinated Specialty Care Through Early Detection: Impact of Reduced Duration of Untreated Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-08
Hadar Hazan, Maria Ferrara, Bin Zhou, Fangyong Li, Shannon Imetovski, Laura A Yoviene Sykes, Jessica Pollard, John Cahill, Toni Gibbs-Dean, Silvia Corbera, Sneha Karmani, Sarah Riley, Sümeyra N Tayfur, Cenk Tek, Matcheri S Keshavan, Vinod H SrihariBackground and Hypothesis Early intervention can improve outcomes for individuals with first-episode psychosis (FEP). We hypothesized that an early detection campaign (ED) targeting the duration of untreated psychosis (DUP) can significantly improve functional outcomes in coordinated specialty care (CSC) patients. Study Design Functional outcomes were compared for FEP patients enrolled from 2014 to
-
Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-07
Stijn Crutzen, Shiral Gangadin, Ken Ho Hua, Ellen Visser, Frederike Jörg, Lisette van der Meer, Gerdina Hendrika Maria Pijnenborg, Wim Veling, Stynke CasteleinBackground Due to the side effects of antipsychotics, overtreatment is an important concern. Previous research focused on antipsychotic polypharmacy and excessively high doses. In this study, the aim is to map changes over the years in potential overtreatment, antipsychotic polypharmacy, total antipsychotic dose, and subjective side effect burden. Moreover, the association of the total dose and antipsychotic
-
Mental Health Professionals’ Perspectives on Digital Remote Monitoring in Services for People with Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-07
Hannah Ball, Emily Eisner, John Ainsworth, Eloise Bagg, Louise Beattie, Matteo Cella, Natalie Chalmers, Sybil Clifford, Richard J Drake, Sophie Faulkner, Kathryn Greenwood, Andrew Gumley, Gillian Haddock, Kimberley M Kendall, Alex Kenny, Jane Lees, Shôn Lewis, Laura Maclean, Jennifer Nicholas, Kathryn O’Hare, Anuoluwapo Oluwatayo, Sandapa Punchihewa, Cara Richardson, Leonie Richardson, Matthias SchwannauerBackground and Hypothesis Digital remote monitoring (DRM) captures service users’ health-related data remotely using devices such as smartphones and wearables. Data can be analyzed using advanced statistical methods (eg, machine learning) and shared with clinicians to aid assessment of people with psychosis’ mental health, enabling timely intervention. Such methods show promise in detecting early signs
-
Latent Trajectories of Positive, Negative Symptoms and Functioning in Early Intervention Services for First-Episode Psychosis: A 2-Year Follow-Up Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-05-04
Olivier Percie du Sert, Joshua Unrau, Manish Dama, Lena Palaniyappan, Jai Shah, Ridha Joober, Delphine Raucher-Chéné, Ashok Malla, Martin LepageBackground From the first episode (FEP), the course of psychosis is marked by substantial heterogeneity of clinical and functional outcomes which poses significant challenges in providing prognostic guidance to patients and families. To better understand such heterogeneity within the context of early intervention services (EIS), this study aimed to examine latent trajectories of positive and negative
-
Deciphering the Heterogeneity of Schizophrenia: A Multimodal and Multivariate Neuroimaging Framework for Unveiling Brain-Symptom Relationships and Underlying Subtypes Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-28
Luli Wei, Wei Liu, Xin Li, Yu Zhang, Yun Luo, Yingying Xie, Liyuan Lin, Zhongyu Chang, Xiaotong Du, Xiaotong Wei, Yi Ji, Zhen Zhao, Meng Liang, Hao Ding, Liping Liu, Xijin Wang, Lina Wang, Hongjun Tian, Gang Wang, Bin Zhang, Juanjuan Ren, Chen Zhang, Chunshui Yu, Wen QinBackground and Hypothesis Schizophrenia manifests large heterogeneities in either symptoms or brain abnormalities. However, the neurobiological basis of symptomatic diversity remains poorly understood. We hypothesized that schizophrenia’s diverse symptoms arise from the interplay of structural and functional alterations across multiple brain regions, rather than isolated abnormalities in a single area
-
Ecological Momentary Assessment of Emotion Regulation and Suicidal Ideation in First-Episode Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-28
Heather M Wastler, Henry R Cowan, Nicholas J K Breitborde, Jeffrey V Tabares, Mengda Yu, Xueliang Pan, Bethany Boettner, Christopher Browning, Craig J BryanIndividuals with first-episode psychosis (FEP) are at increased risk for suicide, though few studies have examined the extent to which emotion regulation abnormalities contribute to this risk. The current study sought to address this gap by examining which stages of emotion regulation (ie, identification, selection, implementation) are related to suicidal ideation among individuals with FEP. Forty-one
-
Disturbed Functional Connectivity Between Anterior Default Mode and Sensory Processing Regions Is Linked to Peripheral Inflammatory Markers and Psychopathology in Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-23
Emanuel Mlynek, Xiaolin Tan, Sarah Edith Lammertz, Sabrina Schaffrath, Gerhard Gründer, Frank Schneider, Thomas Frodl, Klaus Mathiak, Arnim Johannes GaeblerBackground and Hypothesis Both elevated inflammatory markers and aberrant functional connectivity have been detected in patients with schizophrenia, but there is limited knowledge on the relationship between the two phenomena. Some positive symptoms may arise from external misattribution of self-generated actions mediated by decoupling of the default mode network (DMN) with sensory processing regions
-
Abdominal Ultrasound Stimulation Alleviates Negative Symptoms Through Modulation of Serotonin Signaling and Gut Microbiota in the MK-801 Model of Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-19
Feng-Yi Yang, Yi-Ju Pan, Yin-Ting Zheng, Shih-Jen TsaiBackground and Hypothesis Abdominal low-intensity pulsed ultrasound (LIPUS) stimulation has potential as a novel therapeutic strategy against neuroinflammation via inhibition of inflammatory responses in the colon. This study aimed to evaluate whether abdominal LIPUS could alleviate MK-801-induced schizophrenia-like negative symptoms through gut–brain communication. Study Design Rats administered with
-
Combining the Risk: The Poly-Environmental Risk Score and Psychotic Symptoms in Adolescents Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-14
Diandra C Bouter, Susan J Ravensbergen, Nita G M de Neve-Enthoven, Sibel Ercan, Benno Bakker, Mark H de Jong, Witte J G Hoogendijk, Nina H Grootendorst-van MilBackground and Hypothesis Psychotic symptoms are common in adolescents and predictive of psychiatric disorders. Numerous risk factors have been shown to precede psychiatric disorders. However, investigating individual risk factors does not account for the cumulative effect these risk factors may have. Therefore, we combined well-researched environmental risk factors for psychotic disorder in a composite
-
Pharmacologic Augmentation of Computerized Auditory Training in Chronic Psychosis: Preliminary Findings From a Single-Site, Double-Blind Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-14
Neal R Swerdlow, Joyce Sprock, Francesca Li, Jenny Min Din, Jessica Minhas, Jo Talledo, Yash B Joshi, Juan L Molina, Bethany Nordberg, Kevin Ing, Michael L Thomas, Gregory A LightBackground Computerized auditory training (AT) modestly improves symptoms, cognition, and functioning in schizophrenia. We assessed whether d-amphetamine (AMPH) or memantine (MEM) can enhance gains from 30-h of AT. Methods Antipsychotic-medicated individuals with chronic psychosis (n = 68; mean age 47.03y; M:F = 39:29) completed up to 30 AT sessions (2-3/week; n = 50 completed 30 sessions) in 3 groups:
-
The Retinal Age Gap as a Marker of Accelerated Aging in the Early Course of Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-14
Paweł Krukow, Adam Domagała, Adam Kiersztyn, Brittany A Blose, Adriann Lai, Steven M SilversteinBackground and Hypothesis Given the available findings confirming accelerated brain aging in schizophrenia (SZ), we conducted a study aimed at verifying whether quantitative retinal morphological data enable age prediction and whether schizophrenia patients present with a positive retinal age gap (RAG). Study Design Two samples of patients and controls were enrolled: one included 59 SZ patients and
-
Insight and Its Trajectory: Predicting the Risk of Psychiatric Hospitalizations Among First-Episode Psychosis During the First Year of Coordinated Specialty Care Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-14
Hadar Hazan, Maria Ferrara, Toni Gibbs-Dean, Sümeyra N Tayfur, Silvia Corbera, Sneha Karmani, Zhiqian Song, Fangyong Li, Ilias Vlachos, Mirjana Selakovic, Cenk Tek, Vinod H SrihariBackground This study explored how baseline insight predicts psychiatric hospitalization risk among 186 individuals with first-episode psychosis in coordinated specialty care (CSC). We hypothesized that insight, a potentially modifiable factor, moderates the relationship between CSC enrollment and outcomes, with a high baseline and stable high insight predicting greater reductions in hospitalizations
-
Imagery-Focused Cognitive Behavioral Therapy Techniques for Auditory Verbal Hallucinations in Psychosis Spectrum Disorders: Four Experimental Case Series Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-10
Hella Janssen, Karin C van den Berg, Ger P J Keijsers, Georgie Paulik, Katherine Newman-Taylor, Christopher D J Taylor, Craig Steel, Machteld C MarcelisBackground In psychosis spectrum disorders, maladaptive mental imagery is associated with auditory verbal hallucinations (AVHs). This study evaluates the feasibility, acceptability, and effectiveness of the following 4 imagery techniques in targeting mental imagery and AVHs severity: Imagery Rescripting (ImRs), Promoting positive Imagery de novo (Pos-Im), Metacognitive Imagery techniques (Meta-Im)
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-04
Dragana Bugarski-Kirola, I-Yuan Liu, Celso Arango, Stephen R MarderBackground and Hypotheses Negative symptoms of schizophrenia (NSS) carry a substantial burden, and there are no treatments currently approved for NSS. The efficacy of pimavanserin, a selective 5-HT2A inverse agonist and antagonist, in treating NSS was assessed. Study Design ADVANCE-2 was a phase 3, randomized, double-blind, placebo-controlled study of pimavanserin in patients with schizophrenia and
-
Exploring Primary and Interaction Effects of Minor Physical Anomalies: Development and Validation of Prediction Models Using Explainable Machine Learning Algorithms for Early-Onset Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-03
Chih-Wei Lin, Jin-Jia Lin, Huai-Hsuan Tseng, Fong-Lin Jang, Ming-Kun Lu, Po-See Chen, Chih-Chun Huang, Chi-Yu Yao, Tzu-Yun Wang, Wei-Hung Chang, Hung-Pin Tan, Sheng-Hsiang LinBackground and Hypothesis Minor physical abnormalities (MPAs) are neurodevelopmental markers that can be traced to prenatal events and may be significant features of early-onset schizophrenia (EOS). Therefore, our study aimed to (1) find the primary and interaction effects of MPAs for EOS and (2) develop and validate the model for EOS based on explainable machine learning algorithms. Study Design The
-
Digital Phenotyping Measurement of Smartphone Social Behavior is Associated with Illness Progression Risk Scores in Young People at Clinical High Risk for Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2025-04-02
Franchesca S Kuhney, Gregory P Strauss, Elaine F Walker, Sydney H James, Vijay A MittalBackground Young people at clinical high risk for psychosis (CHR-p) commonly experience social impairment, which contributes to functional decline and predicts transition to psychotic illness. Although the use of smart phone technology and social media platforms for social interaction is widespread among today’s youth, it is unclear whether aberrant digital social interactions contribute to risk for
-
Microbiome-Gut-Brain Profiles in Schizophrenia and Their Potential Link to Cognitive Performance: Findings from a Case–Control Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-29
Hui Wu, Xu Jiawei, Zhi Wen, Yunwu Han, Yaxi Liu, Shengyun Chen, Zhiye Ye, Jianbo Li, Liwei Xie, Xiaoli WuBackground Increasing evidence indicates the role of microbiome-gut-brain axis in schizophrenia (SZ). However, few studies have examined the potential links among the gut microbiome, brain structure and function, and clinical manifestation in SZ patients, and the effects of prolonged antipsychotic treatment are often neglected. Study Design A total of 171 participants were enrolled, including 27 drug-naïve
-
Analyzing the Placebo Response and Identifying Influential Factors in Oral Medication Trials for Acute-Phase Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-19
Jiyuan Ren, Lei Zhang, Ling Xu, Yinghua Lv, Jihan Huang, Yulin Feng, Haoyang Guo, Yexuan Wang, Juan Yang, Qingshan Zheng, Lujin LiBackground and Hypothesis This study aims to develop a placebo response and dropout rate model for acute-phase schizophrenia medication trials and assess factors affecting this response to inform future trial design. Study Design We conducted a literature update using a comprehensive meta-analysis of schizophrenia medication trials, focusing on oral placebo-controlled studies. We modeled the placebo
-
Relationship of Perceived Burdensomeness and Thwarted Belongingness to Suicide Ideation Persistence and Suicide Behavior Over 12 Months in People With Serious Mental Illness Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-14
Emma M Parrish, Kevin Kuehn, Amy Pinkham, Raeanne C Moore, Philip D Harvey, Eric Granholm, Scott Roesch, Thomas Joiner, Varsha D Badal, Colin A DeppBackground and Hypothesis People with serious mental illness (SMI) have an increased risk of suicide ideation (SI) and suicide behavior (SB). Longitudinal studies on factors contributing to SI/SB in SMI are lacking. Interpersonal biases (ie, perceived burdensomeness and thwarted belongingness) are cross-sectionally related to SI/SB, but do they relate to longitudinal suicide risk or other illness factors
-
Cerebellar-Cortical Connectivity and Prediction of Antipsychotic Treatment Response in First-Episode Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-10
Halil Aziz Velioglu, Julie Moehringer, Todd Lencz, Juan A Gallego, John Cholewa, Yevgeniy Kats, Anita D Barber, Michael L Birnbaum, Delbert G Robinson, Hengyi Cao, Anil K MalhotraBackground The cerebellum has traditionally been associated with motor functions, but recent evidence highlights its critical role in cognitive and emotional regulation, contributing to the neuropathology of schizophrenia. Our previous data-driven research demonstrated that cerebellar-cortical functional connectivity can predict antipsychotic treatment outcomes in first-episode psychosis (FEP). The
-
Clarifying Fundamental Role of Symbol Coding in Cognitive Networks in Schizophrenia and Healthy Controls Leveraging Gaussian Graphical Models and Bayesian Networks Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-06
Yuyanan Zhang, Yaoyao Sun, Zhe Lu, Guorui Zhao, Junyuan Sun, Xiao Zhang, Yang Yang, Zhewei Kang, Xiaoyang Feng, Rui Yuan, Yundan Liao, Yunqing Zhu, Jing Guo, Weihua YueBackground and Hypothesis Cognitive impairments in patients with schizophrenia initiate a cascade of effects on daily functioning. A single impairment can affect the functioning of the entire cognitive system. However, the relative interdependence among individual neuropsychological measures—whether the performance of a specific test depends on other tests—remains poorly understood. Study Design The
-
Capturing Motor Signs in Psychosis: How the New Technologies Can Improve Assessment and Treatment? Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Juliette Lozano-Goupil, Vijay A MittalMotor signs are critical features of psychosis that remain underutilized in clinical practice. These signs, including social motor behaviors, mechanistically relevant motor signs, and other motor abnormalities, have demonstrated potential as biomarkers for early detection and intervention. However, their application in clinical settings remains limited due to challenges such as cost, accessibility
-
Predictive Validity of Psychometrically Assessed Schizotypy for Psychopathology Dimensions and Functioning in an 8-Year Multiwave Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Neus Barrantes-Vidal, Thomas R KwapilBackground and Hypothesis Although the psychometric high-risk method based on schizotypy has proven to be a highly cost-effective strategy for unraveling etiological factors for schizophrenia-spectrum disorders, there is a paucity of longitudinal studies with nonclinical populations. This study analyzed the predictive validity of positive and negative schizotypy in a longitudinal project (Barcelona
-
Personal Goal-Related Mental Time Travel and Its Association With Resting-State Functional Connectivity in Individuals With High Schizotypal Traits Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Jun-yan Ye, Xiao-jing Qin, Ji-fang Cui, Jia-li Liu, Hai-song Shi, Tian-xiao Yang, Ya Wang, Raymond C K ChanBackground and Hypothesis Mental time travel (MTT) is a crucial ability for daily life. Personal goal-related MTT events has stronger phenomenological characteristics than personal goal-unrelated ones, ie, the “personal goal-advantage effect”. However, it remains unclear whether this effect is impacted in individuals with high schizotypal traits (HST) and the neural correlates of this effect have yet
-
Schizotypal Traits, Psychopathology, and Reflective Functioning Impairments During Adolescence: A Bayesian Network Approach Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Eduardo Fonseca-Pedrero, Alicia Pérez-Albéniz, Beatriz Lucas-Molina, Susana Al-Halabí, Martin DebbanéBackground New theoretical and measurement models related to Bayesian networks can usefully be implemented to enrich our understanding of psychosis risk. The present study aims to explore, using a directed acyclic graph (DAG), the putative causal relationship within schizotypal facets, as well as between schizotypal dimensions, psychopathology, and reflective functioning (RF) impairments, in a representative
-
Default Mode Network, Disorganization, and Treatment-Resistant Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Huan Huang, Xuan Qin, Rui Xu, Ying Xiong, Keke Hao, Cheng Chen, Qirong Wan, Hao Liu, Wei Yuan, Yunlong Peng, Yuan Zhou, Huiling Wang, Lena PalaniyappanBackground and Hypothesis Disorganized thinking is a prominent feature of schizophrenia that becomes persistent in the presence of treatment resistance. Disruption of the default mode network (DMN), which regulates self-referential thinking, is now a well-established feature of schizophrenia. However, we do not know if DMN disruption affects disorganization and contributes to treatment-resistant schizophrenia
-
Negative Schizotypy Associated With Weaker Intersubject Correlation in Dynamic Functional Connectivity During Empathic Accuracy Task Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Ding-ding Hu, Xiao-dong Guo, Simon S Y Lui, Yi Wang, Raymond C K ChanBackground and Hypothesis Previous studies on Empathic Accuracy Task (EAT) suggested patients with schizophrenia exhibited altered brain activations in the precuneus, middle frontal gyrus, and thalamus. However, it remains unclear whether individuals with schizotypy would exhibit similar alterations of brain activations associated with EAT. This study aimed to examine the relationships between schizotypy
-
Relationship Between Schizotypal Traits, Emotion Regulation, and Negative Affect in Children: A Network Analysis Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Qian Ren, Tian-xiao Yang, Yi Wang, Simon S Y Lui, Raymond C K ChanBackground and Hypothesis Evidence suggests that emotion regulation is related to schizotypal traits and negative affect in adults. Few studies examined the interplay among these constructs in school-aged children. We examined the complex relationship between schizotypal traits, emotion regulation, and negative affect in children aged 9–12 years. Study Design One-thousand-and-nineteen children completed
-
Amygdala Function, Blood Flow, and Functional Connectivity in Nonclinical Schizotypy Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Igor Nenadić, Jonas Hoffmann, Andrea Federspiel, Sebastian Walther, Ahmad Abu-Akel, Andreas Jansen, Tina MellerBackground and Hypothesis Schizotypy can be utilized as a phenotypic risk marker for schizophrenia and its spectrum and might relate to putative dimensional biological markers of the psychosis spectrum. Among these are amygdala function and structure, which are impaired in schizophrenia, but possibly also correlated with subclinical expression of schizotypy in nonclinical samples. We tested whether
-
The Relationship Between Schizotypal Personality Traits and Temporal Discounting: The Role of the Date/Delay Effect Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Kristof Keidel, Carsten Murawski, Christos Pantelis, Ulrich EttingerBackground and Hypothesis Many patients with psychiatric disorders show increased temporal discounting (TD), ie, they discount future rewards more steeply than healthy controls. However, findings for schizophrenia and schizotypy, a personality constellation considered to be on the schizophrenia spectcrum, are less clear. Moreover, the role of future time representation in TD in the schizophrenia spectrum
-
Schizotypy, Psychosis Proneness, and the Polygenic Risk for Schizophrenia and Resilience Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Tina Meller, Clara Lundberg, Carlo Maj, Per Hoffmann, Andreas J Forstner, Markus M Nöthen, Igor NenadićBackground and Hypothesis Schizotypy is a well-established phenotype for psychosis proneness and risk. Yet, its genetic underpinnings and relations to genetic bases of the schizophrenia spectrum are not well understood owing to conflicting findings. In a deep phenotyping approach, we hypothesized that genetic markers of risk for and to schizophrenia are differentially associated with (trait-level)
-
The Relationship Among Range Adaptation, Social Anhedonia, and Social Functioning: A Combined Magnetic Resonance Spectroscopy and Resting-State fMRI Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Ling-ling Wang, Gai-ying Li, Chao Yan, Yi Wang, Yan Gao, Ya Wang, Simon S Y Lui, Jian-Qi Li, Raymond C K ChanBackground and Hypothesis Social anhedonia is a core feature of schizotypy and correlates significantly with social functioning and range adaptation. Range adaptation refers to representing a stimulus value based on its relative position in the range of pre-experienced values. This study aimed to examine the resting-state neural correlates of range adaptation and its associations with social anhedonia
-
Differential Association of Schizotypy Dimensions With Brain Structural Connectivity and Moderation by Schizophrenia Polygenic Risk Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Jonas Hoffmann, Tina Meller, Carlo Maj, Per Hoffmann, Andreas J Forstner, Markus M Nöthen, Igor NenadićObjective Schizotypy as a psychosis proneness marker has facilitated the study of schizophrenia spectrum models, linking phenotypic psychosis risk to brain structural and functional variation. However, association studies to structural connectome markers are limited and often do not consider relations to genetic risk. We tested the hypothesis that dimensions of schizotypy (rather than overall phenotype
-
Fronto-Thalamic Structural Connectivity Associated With Schizotypy, a Psychosis Risk Phenotype, in Nonclinical Subjects Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Igor Nenadić, Johannes Mosebach, Simon Schmitt, Tina Meller, Frederike Stein, Katharina Brosch, Kai Ringwald, Julia-Katharina Pfarr, Susanne Meinert, Hannah Lemke, Lena Waltemate, Katharina Thiel, Nils Opel, Jonathan Repple, Dominik Grotegerd, Olaf Steinsträter, Jens Sommer, Tim Hahn, Andreas Jansen, Udo Dannlowski, Axel Krug, Tilo KircherBackground and Hypothesis Schizotypy is a risk phenotype for the psychosis spectrum and pilot studies suggest a biological continuum underlying this phenotype across health and disease. It is unclear whether this biological continuum might include brain structural associations in networks altered in schizophrenia spectrum disorders, such as the fronto-thalamo-striatal system or nodes of the default
-
Longitudinal Associations Between Self-reported Schizotypy Dimensions and White Matter Integrity Development During Adolescence Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Mélodie Derome, Suje Amir, Elodie Sprüngli-Toffel, George Salaminios, Eduardo FonsecaPedrero, Martin DebbanéBackground Alterations of white matter microstructure have been reported in the psychosis spectrum. However, the development of these alterations during preclinical stages remains poorly understood. The framework proposed by schizotypy research as the personality base for liability to develop psychosis spectrum disorders offers 3 interconnected dimensions thought to impact neurodevelopment, affording
-
Reduced Visual Function in Schizotypal Traits: An Exploratory Study Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Emsal Llapashtica, John L Barbur, Corinna HaenschelBackground and Hypothesis Visual impairments have been proposed as risk factors for psychotic symptoms and illnesses. Visual impairments can considerably impact people’s daily lives, but little is known about the impact and diagnostic sensitivity of such abnormalities for schizotypal personality traits. This study aims to explore possible relationships between schizotypy and visual acuity (VA), contrast
-
Genetic Differences in Reactivity to the Environment Impact Psychotic-Like and Affective Reactivity in Daily Life Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-05
Neus Barrantes-Vidal, Pilar Torrecilla, Patricia Mas-Bermejo, Sergi Papiol, Marian J Bakermans-Kranenburg, Araceli Rosa, Thomas R KwapilBackground and Hypothesis Consistent with diathesis-stress models, psychosis research has focused on genetic moderation of adverse environmental exposures. In contrast, the Differential Susceptibility (DS) model suggests that the same genetic variants that increase risk-inducing effects of adverse experiences also enhance beneficial effects from positive experiences. This study examined whether individuals
-
Polygenic Resilience Scores are Associated With Lower Penetrance of Schizophrenia Risk Genes, Protection Against Psychiatric and Medical Disorders, and Enhanced Mental Well-Being and Cognition Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-04
Jonathan L Hess, Eric J Barnett, Jiahui Hou, Stephen V Faraone, Stephen J GlattBackground and Hypothesis In the past decade, significant advances have been made in finding genomic risk loci for schizophrenia (SCZ). This, in turn, has enabled the search for SCZ resilience loci that mitigate the impact of SCZ risk genes. We identified the first genomic resilience profile for SCZ, completely independent from known risk loci for SCZ, though it remains unclear whether resilience loci
-
Potential Delayed Positive Effects of tDCS on Improving Introspective Accuracy in Social Cognition in Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-04
Linlin Fan, Emily Bass, Hans Klein, Cassi Springfield, Sven Vanneste, Amy E PinkhamBackground and Hypothesis Impairments in introspective accuracy (IA) are prominent among schizophrenia patients and detrimentally affect daily functioning, making IA a potential therapeutic target. Recent research highlights the role of the right rostrolateral prefrontal cortex (rlPFC) in IA and suggests that transcranial direct current stimulation (tDCS) to this region may improve it. Therefore, we
-
Peripheral Microvascular and Cerebral White Matter Dysfunction in Schizophrenia: Implications of a Body-Brain Endothelial Pathophysiology Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-04
Eric L Goldwaser, Alexa Yuen, Wyatt Marshall, Bhim M Adhikari, Joshua Chiappelli, Andrew van der Vaart, Mark Kvarta, Yizhou Ma, Xiaoming Du, Si Gao, Heather Bruce, Patrick Donnelly, Braxton Mitchell, Charles Hong, Danny J J Wang, Peter Kochunov, L Elliot HongBackground and Hypothesis Schizophrenia spectrum disorder (SSD) is a chronic neuropsychiatric illness accompanied by significant brain structural and functional abnormalities and higher rate of cardio- and cerebrovascular comorbidities. We hypothesized that genetic and environmental risk factors that led to SSD act throughout the body and demonstrated the association between lower integrity of peripheral
-
Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum Disorders Schizophr. Bull. (IF 5.3) Pub Date : 2025-03-04
Ayesha G Rashidi, Lindsay D Oliver, Iska Moxon-Emre, Colin Hawco, Erin W Dickie, Ruyi Pan, Maria T Secara, Ju-Chi Yu, Peter Szatmari, Pushpal Desarkar, George Foussias, Robert W Buchanan, Anil K Malhotra, Meng-Chuan Lai, Aristotle N Voineskos, Stephanie H AmeisBackground and Hypothesis Social cognitive and neurocognitive performance is impacted in autism and schizophrenia spectrum disorders (SSDs). Here, we compared social cognitive and neurocognitive performance across a large transdiagnostic sample of participants with autism, SSDs, and typically developing controls (TDCs). Study Design Participants (total N = 584; autism N = 100, SSDs N = 275, TDCs N